|
Market Closed -
Nasdaq
00:00:00 07/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 6.320 USD | +1.94% |
|
-7.47% | -40.88% |
| 09-28 | CapsoVision, Inc. Announces Fda Clearance of Ai Highlights for Capsocam Plus | CI |
| 09-28 | CapsoVision Gets FDA Clearance for AI-Assisted Capsule Endoscopy Tool | MT |
| Market Cap | 316M 284M 259M 237M 446M 29.73B 460M 3.13B 1.25B 15.86B 1.19B 1.16B 50.08B | P/E 2026 * |
-11.3x | P/E 2027 * | -14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 316M 284M 259M 237M 446M 29.73B 460M 3.13B 1.25B 15.86B 1.19B 1.16B 50.08B | EV / Sales 2026 * |
21.3x | EV / Sales 2027 * | 16x |
| Free-Float |
66.26% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript: CapsoVision, Inc.
| 1 day | +1.94% | ||
| 1 week | -7.47% | ||
| Current month | -7.47% | ||
| 1 month | -4.53% | ||
| 3 months | -10.99% | ||
| 6 months | -11.24% | ||
| Current year | -40.88% |
| 1 week | 6.12 | 7.05 | |
| 1 month | 6.12 | 7.23 | |
| Current year | 4.5 | 11.37 | |
| 1 year | 4.5 | 15.37 | |
| 3 years | 3.43 | 15.37 | |
| 5 years | 3.43 | 15.37 | |
| 10 years | 3.43 | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/18/26 A | Buy | Director | 1,757,469 | 3.5263% | ||
| 9/15/26 A | Buy | 878,734 | 1.7632% | |||
| 9/15/26 A | Buy | 878,734 | 1.7632% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.94% | -7.47% | +33.62% | - | 316M | ||
| +2.63% | -0.32% | +21.37% | +52.93% | 257B | ||
| +1.73% | -0.85% | +9.67% | +16.99% | 162B | ||
| -3.36% | +4.81% | -19.14% | +62.92% | 157B | ||
| -4.23% | +1.83% | -57.26% | -17.96% | 61.96B | ||
| +1.31% | +11.01% | +22.48% | +54.20% | 58.73B | ||
| -2.72% | +0.12% | +0.21% | -10.10% | 55.42B | ||
| +1.73% | -0.06% | +19.09% | +59.76% | 49.27B | ||
| -2.05% | -2.95% | +3.01% | +56.46% | 49.18B | ||
| +1.00% | -1.11% | +23.11% | +78.88% | 44.96B | ||
| Average | +0.19% | +0.90% | +5.62% | +39.34% | 89.62B | |
| Weighted average by Cap. | +0.03% | +1.48% | +4.45% | +41.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 13.34M 12.19M 11.13M 20.97M 1.4B 21.63M 147M 58.59M 746M 55.82M 54.63M 2.35B | 19.82M 17.78M 16.25M 14.83M 27.94M 1.86B 28.83M 196M 78.09M 994M 74.4M 72.81M 3.14B |
| Net income | -27.56M -24.71M -22.59M -20.62M -38.85M -2.59B -40.07M -272M -109M -1.38B -103M -101M -4.36B | -22.1M -19.82M -18.12M -16.54M -31.16M -2.08B -32.14M -218M -87.07M -1.11B -82.95M -81.17M -3.5B |
| Net Debt | - | - |
Employees
99
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | $6.320 | +1.94% | 119,883 |
| 05/11/26 | $6.200 | -9.49% | 141,935 |
| 04/11/26 | $6.850 | +2.24% | 135,982 |
| 03/11/26 | $6.700 | -0.45% | 245,924 |
| 02/11/26 | $6.730 | -1.46% | 104,484 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.320USD
Average target price
9.500USD
Spread / Average Target
+50.32%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions

















